Ketone Supplement Exercise Performance Meta-analysis: What the Evidence Says
Ketone Supplement Exercise Performance Meta-analysis has 2 source documents in the current Migaku evidence database. The strongest available sources in this f
Quick Answer
Ketone Supplement Exercise Performance Meta analysis has 2 source documents in the current Migaku evidence database. The strongest available sources in this first pass are systematic review, so conclusions should be framed as evidence aware guidance rather than medical advice.
Key Takeaways
- 01This page is generated only from sources stored in the Migaku evidence knowledge base.
- 02Current evidence mix: 1 systematic review, 1 research article.
- 03Claims should be interpreted with the source type, study design, population, and publication date in mind.
- 04This article is educational and does not replace care from a qualified clinician.
Ketone Supplement Exercise Performance Meta-analysis: What the Evidence Says
Quick Answer
Ketone Supplement Exercise Performance Meta-analysis has 2 source documents in the current Migaku evidence database. The strongest available sources in this first pass are systematic review, so conclusions should be framed as evidence-aware guidance rather than medical advice.
Key Takeaways
- This page is generated only from sources stored in the Migaku evidence knowledge base.
- Current evidence mix: 1 systematic review, 1 research article.
- Claims should be interpreted with the source type, study design, population, and publication date in mind.
- This article is educational and does not replace care from a qualified clinician.
Evidence Map
| Source | Evidence type | Level | Date | Identifier |
|---|---|---|---|---|
| The effect of exogenous ketone bodies on cognition across health and disease: a systematic review and meta-analysis | systematic review | 1 | 2026-04-15 | 10.3389/fnut.2026.1802531 |
| An extract from whole Coffea arabica coffee cherry improves time trial performance, but not muscle glycogen resynthesis, in trained cyclists | research article | 4 | 2026-06-03 | 10.1080/15502783.2026.2682323 |
What The Sources Report
- In addition to the reduced quality of life and wellbeing for the patient, ADRD also imposes a cost on society through the significant financial burden of patient care. [Bonnechère Bruno (2026); evidence level 1]
- All participants met the classification of being Tier 2 athletes, and habitual caffeine use was chosen to minimize the risk of adverse events from unaccustomed caffeine intake. [Pavis George F. (2026); evidence level 4]
- From baseline, plasma caffeine concentration remained unchanged with PLA throughout SS, but was elevated by CB immediately prior to, and at 10, 20 and 30 mins of SS (interaction < 0.001; all timepoints increased from baseline, and greater than PLA; post hoc < 0.001). [Pavis George F. (2026); evidence level 4]
How To Read This Evidence
Evidence level 1 generally reflects systematic reviews or meta-analyses. Level 2 includes randomized trials, guidelines, or public-health guidance. Level 3 usually reflects observational or narrative-review evidence. Level 4 is weaker or early-stage evidence. The level is a sorting aid, not a final quality grade.
Practical Interpretation
There is at least one systematic-review style source in the current set, so it deserves more weight than single-study evidence. For ketone supplement exercise performance meta-analysis, the next editorial step is to add more targeted sources and separate strong findings from early or indirect evidence.
Limits Of This First Pass
This is a small-batch MVP article. It uses the first ingested sources for this topic and should be expanded with more targeted searches, license review, and human editorial checks before being treated as a definitive review.
References
- Bonnechère Bruno (2026). The effect of exogenous ketone bodies on cognition across health and disease: a systematic review and meta-analysis. DOI: 10.3389/fnut.2026.1802531. PMCID: PMC13127162. PMID: 42063954. License: CC BY 4.0. https://pmc.ncbi.nlm.nih.gov/articles/PMC13127162/
- Pavis George F. (2026). An extract from whole Coffea arabica coffee cherry improves time trial performance, but not muscle glycogen resynthesis, in trained cyclists. DOI: 10.1080/15502783.2026.2682323. PMCID: PMC13235231. PMID: 42234539. License: CC BY 4.0. https://pmc.ncbi.nlm.nih.gov/articles/PMC13235231/
Safety Note
Health information can change, and individual risk depends on medical history, medications, pregnancy status, age, and diagnosis. Talk with a qualified clinician before changing treatment, supplement, or medication routines.
FAQ
Frequently Asked Questions
Medically reviewed
Last reviewed August 12, 2026 by Migaku Evidence Review
